Looking for our Business Solutions? Click here:CloudQuote APIsContact Us
Home
Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

3 Growth Stocks That Could Skyrocket in 2025 and Beyondfool.com
If bulls are winning back the market, these speedsters can help you stay ahead of your fellow investors.
Via The Motley Fool · May 5, 2025
Why Frontline Stock Popped, but Exxon and ConocoPhillips Droppedfool.com
There's one great reason why Frontline is outperforming Exxon and Conoco stocks today.
Via The Motley Fool · May 5, 2025
Why USA Rare Earth Stock Powered 76.9% Higher in Aprilfool.com
Via The Motley Fool · May 5, 2025
Why This Could Be an Extremely Volatile Week for Nvidiafool.com
Via The Motley Fool · May 5, 2025
Here's Why Comfort Systems Soared More Than 23% in April and Is Set to Be a Winner in Trump's Presidencyfool.com
Via The Motley Fool · May 5, 2025
Why Nvidia, Microsoft, and Meta Platforms Investors Just Had an Amazing Weekfool.com
Via The Motley Fool · May 5, 2025
What Super Micro, Unity Software, and Altera Labs Stock Investors Should Know About Upcoming Earningsfool.com
Via The Motley Fool · May 5, 2025
GBP/USD Forex Signal: Forecast Ahead Of Fed And BoE Decisionstalkmarkets.com
The GBP/USD pair pulled back for four straight days as the recent bullish momentum faded.
Via Talk Markets · May 5, 2025
Is Starbucks Serving Up Promise or Peril?fool.com
Same-store sales are down at the coffee chain's U.S. stores. But a successful turnaround isn't off the menu yet.
Via The Motley Fool · May 5, 2025
Small Businesses Will Get Hit The Hardest By Trump’s Tariffstalkmarkets.com
Small businesses were already struggling. Tariffs will end the viability of many.
Via Talk Markets · May 5, 2025
OPEC Shifts To Oil Price-War Stance Ahead Of Trump Saudi Visitinvestors.com
Oil prices slumped Monday, after OPEC accelerated its production increase for a third month ahead of a Saudi visit by President Trump.
Via Investor's Business Daily · May 5, 2025
Capricor Therapeutics Stock Tumbles After FDA Confirms Intent To Hold Advisory Committee Meet For Deramiocel Approval: But Retail’s Optimisticstocktwits.com
The U.S. FDA stated that its review committee has identified no significant deficiencies and is on track to make a decision on the application by its deadline of the end of August.
Via Stocktwits · May 5, 2025
Why Broadcom Stock Jumped 15% in Aprilfool.com
Via The Motley Fool · May 5, 2025
Crude Oil Finds Support After Gap Down, Eyes Gap Fill Amid Downside HTF Bias And Mixed Macro Signalscontent/com
Crude oil opened with a gap down, but initial absorption led to a pullback higher, supported by the prior session’s b-shaped profile structure, suggesting a bullish bias in the short term.
Via Talk Markets · May 5, 2025
Why Walmart Stock Jumped 11% in Aprilfool.com
Via The Motley Fool · May 5, 2025
Dollar Selling Persists Despite US Jobs Reporttalkmarkets.com
The U.S. Dollar remains under pressure despite a robust April Nonfarm Payrolls report of 177,000 jobs, as markets focus on the ongoing impact of President Trump’s tariff policies.
Via Talk Markets · May 5, 2025
These Analysts Cut Their Forecasts On Wendy's After Q1 Resultsbenzinga.com
Via Benzinga · May 5, 2025
Book More Profits, Buffett's Company Reports Worst Earnings Drop Since 2020, OPEC+ Surprisebenzinga.com
Via Benzinga · May 5, 2025
FiscalNote Sells TimeBase To Thomson Reuters For $6.5M, Reaffirms 2025 Outlookbenzinga.com
FiscalNote (NYSE: NOTE) to sell Australian subsidiary to Thomson Reuters (NASDAQ: TRI) for $6.5M. Supports strategy to streamline operations and refocus on core strengths. Maintains FY25 guidance.
Via Benzinga · May 5, 2025
A Steady Business During Uncertain Timesfool.com
Via The Motley Fool · May 5, 2025
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · May 5, 2025
Buy This Dividend Stock Paying A 9% Yield With 100% Capital Appreciation Potentialtalkmarkets.com
On April 25, finance REIT Rithm Capital reported the company’s first-quarter results, and the financials reinforced the fact that the RITM stock price is severely undervalued.
Via Talk Markets · May 5, 2025
Eaton Analysts Increase Their Forecasts After Better-Than-Expected Q1 Resultsbenzinga.com
Via Benzinga · May 5, 2025
Axsome Therapeutics Clocks Around 60% Topline Growth In Q1benzinga.com
Axsome beat Q1 expectations with $121.5 million in revenue and strong Auvelity sales as it prepares Symbravo's U.S. launch and advances key drug programs.
Via Benzinga · May 5, 2025
Bitcoin Could Hit $450,000, Raoul Pal Says: 'Don't Screw This Up'benzinga.com
Bitcoin (CRYPTO: BTC) and crypto markets are entering the second leg of what macro expert Raoul Pal calls the "banana zone", a steep, liquidity-driven bull phase.
Via Benzinga · May 5, 2025